Arthritis & Rheumatism · 1994 · 52 citations · 25 references
MedicineImmunologyInternal MedicineAutoimmunityInflammationRheumatologyAutoimmune Rheumatic DiseasesInflammatory ArthritisJoint DiseaseJoint PathologyRheumatoid ArthritisSynovial InflammationAngiogenic CytokinesAngiogenic Factor ExpressionAngiogenic ModulationSynovial BiomarkersSynovial FibroblastsSynovial Fluid BiomarkersSynovial Fluid Protein AnalysisVascular Endothelial Growth Factor
OBJECTIVE: To purify a protein inhibitor from rheumatoid arthritis (RA) synovial fluids which suppresses the apparent incorporation of 3H-thymidine into fibroblasts and synovial cells, and to define its biochemical features that have clinical relevance to the pathogenesis of RA. METHODS: Several standard chromatographic techniques were employed for the purification of the protein. Immunochemical methods with monoclonal antibody were used to quantify and visualize the protein in sera, synovial fluids, and tissues from RA patients. RESULTS: The chemical properties of purified inhibitor from RA synovial fluids confirmed its identity as gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF), a potent angiogenic factor. The gliostatin/PD-ECGF level in synovial fluid and serum was higher in RA patients than in osteoarthritis controls. CONCLUSION: These findings strongly suggest that gliostatin/PD-ECGF might play an important role in the aberrant neovascularization of rheumatoid synovium.
25
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
S M Hsu, Laurence Raine, Herbert Fanger · Journal of Histochemistry & Cytochemistry · 1981 · 14.3K citations · Full text
Differentiated Rat Glial Cell Strain in Tissue Culture
Philippe Benda, J. Lightbody, Gordon Sato et al. · Science · 1968 · 1.5K citations